EMA Application withdrawn: Ramvocid — Targanta Netherlands B.V.

View source ↗

Summary

The EMA withdrew the Ramvocid application by Targanta Netherlands B.V. for Gram-positive bacterial infections, skin diseases, and soft tissue infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gram-positive Bacterial Infections
• Skin Diseases
• Soft Tissue Infections

Drugs mentioned

• Ramvocid (oritavancin)

Snippet

Status: Application withdrawn. Therapeutic area: Gram-Positive Bacterial Infections;Skin Diseases, Bacterial;Soft Tissue Infections. MAH: Targanta Netherlands B.V.. Decision date: 31/12/2009